Clinical Trials in the Media

This media analysis report evaluates the media conversation around clinical trials in the pharmaceutical and biotechnology industries in English-language editorial coverage.

The research employs a set of metrics that can be utilised for benchmarking and competitive analysis. These include share of voice, key business events and topics, media impact score, and most influential spokespeople and key opinion leaders (KOLs) in the discussion.

It covers 250 pharmaceutical and biotechnology companies, and is based on 73,148 English-language articles published between Jan – Aug 2023 in 3,490 media outlets.